低粉和低糖饮食在IBS-A随机非劣势性研究中具有与低FODMAP相似的效率
Bodil Roth1,2, Mohamed Nseir1, Håkan Jeppsson3
1Department of Clinical Sciences, Lund University, 221 00 Lund, Sweden.
Nutrients
|September 14, 2024
概括
低粉和低糖饮食 (SSRD) 与低FODMAP饮食同样有效,可以缓解刺激性肠综合征 (IBS) 的症状. 此外,SSRD还显示体重,BMI和糖的渴望减少.
科学领域:
- 胃肠病学 胃肠病学
- 饮食干预 饮食干预
- 临床营养学 临床营养学
背景情况:
- 低FODMAP饮食是一种标准的IBS治疗方法.
- 低粉和低糖饮食 (SSRD) 对IBS有希望.
- 需要在SSRD和低FODMAP饮食之间进行比较的疗效数据.
研究的目的:
- 为了比较IBS患者的SSRD与低FODMAP饮食的响应率.
- 评估SSRD和低FODMAP饮食对各种IBS相关症状和参数的影响.
主要方法:
- 随机非劣势性研究,对155名IBS患者进行.
- 干预组:SSRD (n=77) 和低FODMAP (n=78) 在4周内.
- 结果措施包括IBS-SSS,肠外症状,体重,BMI和血压,随访6个月.
主要成果:
- 在第2周和第4周的响应率中,SSRD与低FODMAP饮食无差.
- 这两种饮食都显著改善了胃肠道和肠外症状.
- 与低FODMAP相比,SSRD导致体重,BMI和糖渴望的减少更大.
结论:
- 4周的SSRD干预对IBS症状反应来说不低于低FODMAP饮食.
- 这两种饮食方法都有效地减少了胃肠道和肠外症状.
- SSRD在体重管理和减少对糖的渴望方面提供了额外的好处.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
324
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
324
Drugs for Treatment of Diarrhea-Predominant IBS
153
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
153
Irritable Bowel Syndrome III: Medical and Nursing Management
180
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
180
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
147
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
147
Drugs for Treatment of Constipation-Predominant IBS
145
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
145
Irritable Bowel Syndrome I: Introduction
257
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
257


